US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 15.900
  • +0.130+0.82%
Close Feb 14 16:00 ET
  • 15.900
  • 0.0000.00%
Post 16:01 ET
581.57MMarket Cap-8.10P/E (TTM)

About Rapport Therapeutics Company

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Company Profile

SymbolRAPP
Company NameRapport Therapeutics
Listing DateJun 7, 2024
Issue Price17.00
Founded2022
CEOMr. Abraham N. Ceesay, M.B.A.
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address1325 Boylston Street,Suite 401
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-321-8020
Websitehttp://www.rapportrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Abraham N. Ceesay, M.B.A.
  • Chief Executive Officer and Director
  • 2.42M
  • David Bredt, M.D.,PhD
  • Chief Scientific Officer and Director
  • --
  • Dr. Swamy Yeleswaram, PhD
  • Chief Development Officer
  • --
  • Dr. Bradley S. Galer, M.D.
  • Chief Medical Officer
  • --
  • Cheryl Gault
  • Chief Operating Officer
  • 1.78M
  • Kathy Wilkinson
  • Chief People Officer
  • --
  • Troy A. Ignelzi
  • Chief Financial Officer
  • 2.13M
  • Dr. Steven M. Paul, M.D.
  • Chairman of the Board
  • 568.99K
  • Dr. Jeffrey K. Tong, PhD
  • Director
  • 55.50K
  • Raymond Kelleher, M.D.,PhD
  • Director
  • --
  • Terry-Ann Burrell, M.B.A.
  • Director
  • --
  • Dr. James I. Healy, M.D.,PhD
  • Director
  • --
  • Dr. John M. Maraganore,PhD
  • Director
  • --
  • Dr. Reid M. Huber, PhD
  • Director
  • 400.26K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
GCOM
838924
+25.08%
XINGANJIANG
873167
+24.11%
4
Beijing Highlander Digital Technology
300065
+20.05%
5
Hangzhou Gaoxin Materials Technology
300478
+20.02%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.